Roivant Sciences Ltd. (ROIV) delivered a return of 174.74% over the past year. Since ROIV does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Roivant Sciences Ltd. one year ago would be worth $27,474 today, representing a gain of $17,474.

Roivant Sciences Ltd. (ROIV) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ROIV, the total return equals the price-only return.

Yes, Roivant Sciences Ltd. (ROIV) outperformed the S&P 500 by 149.75 percentage points over the past year. ROIV delivered a total return of 174.74%, compared to the S&P 500's 24.99%. This 149.75pp alpha means investors in ROIV earned more than a passive S&P 500 index fund.

Roivant Sciences Ltd. (ROIV) experienced a maximum drawdown of -12.84% over the past year, declining from its peak on 2026-05-20 to its trough on 2026-06-02. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Roivant Sciences Ltd. (ROIV)'s long-term returns with dividends reinvested. Over 10 years, the total return is 202.2% (11.7% CAGR) — $10,000 would have grown to $30,221. Over 20 years: 202.2% total return (5.7% CAGR) — $10,000 → $30,221. Over 30 years: 202.2% total return (3.8% CAGR) — $10,000 → $30,221. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Roivant Sciences Ltd.'s best calendar year was 2025 with a total return of 79.6%. Its worst year was 2022 with a total return of -19.4%. This range shows the volatility investors should expect — the difference between the best and worst year is 99.0 percentage points.